Olorinab inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins.
Molecular Weight
357.41
Molecular Formula
C18H23N5O3
Form
Lyophilized powder
Purity
>98%
Applications
Olorinab can be used for its ability to modulate pain perception and inflammation without the psychoactive effects typically associated with activating CB1 receptors.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
